Cubist Systematic Strategies’s ClearPoint Neuro CLPT Stock Holding History

Cubist Systematic Strategies’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-61,047	Closed	-$726K	–	3041
2025 Q1	$726K	Sell	61,047 -4,544	-7%	-$70.6K	﹤0.01%	1981
2024 Q4	$1.01M	Buy	65,591 +12,372	+23%	+$160K	0.01%	1786
2024 Q3	$597K	Sell	53,219 -24,531	-32%	-$235K	﹤0.01%	2131
2024 Q2	$419K	Buy	+77,750	New	+$450K	﹤0.01%	2209
2023 Q2	–	Sell	-4,495	Closed	-$37.9K	–	3600
2023 Q1	$37.9K	Buy	+4,495	New	+$39.4K	﹤0.01%	3605
2022 Q3	–	Sell	-29,444	Closed	-$384K	–	4451
2022 Q2	$384K	Buy	+29,444	New	+$301K	﹤0.01%	3264
2021 Q4	–	Sell	-12,371	Closed	-$220K	–	3482
2021 Q3	$220K	Sell	12,371 -6,076	-33%	-$114K	﹤0.01%	2535
2021 Q2	$352K	Buy	+18,447	New	+$356K	﹤0.01%	2233

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Cubist Systematic Strategies's CLPT Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 61,047 shares — an estimated $726K sold.

Cubist Systematic Strategies first reported a position in CLPT in Q2 2021 and held it in 8 quarters. The position peaked at $1.01M in Q4 2024. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

Cubist Systematic Strategies reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 61,047 ClearPoint Neuro shares in Q2 2025, an estimated $726K.
Cubist Systematic Strategies first reported a position in ClearPoint Neuro in Q2 2021 and held it in 8 quarters.
Cubist Systematic Strategies's ClearPoint Neuro position peaked at $1.01M in Q4 2024.
96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.